1. Aytu BioScience Appoints Steven Boyd to the Company's Board of Directors

    Aytu BioScience Appoints Steven Boyd to the Company's Board of Directors

    ENGLEWOOD, CO / ACCESSWIRE / April 16, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical needs, today announced the formal appointment of Steven Boyd, Founder and Chief Investment Officer of Armistice Capital, to the Aytu BioScience board of directors. As previously announced in December 2018, the company planned to formally appoint Mr. Boyd at an upcoming board of directors meeting in early 2019. The board of directors formally appointed Mr. Boyd at a board meeting held April 15, 2019...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned